Locations:
Search IconSearch
October 20, 2014/Cancer/Patient Support

Why Mental Health is the Missing Piece in Cancer Care

Addressing the unmet mental health needs of cancer patients provides a comprehensive approach to survival

mentalhealth_690x380

Approximately 25 percent to 30 percent of patients in the cancer setting will experience depression or anxiety—rates that greatly exceed those seen in the general population.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

According to the literature, these figures are likely underestimates, too. The impact of depression and anxiety can be critical, underscoring the importance of addressing mental health concerns as part of treatment.

In the early stages of cancer intervention, physicians and other practitioners tend to focus on treating the disease. As a result, individuals with mental health needs can slip under the radar. Evidence suggests oncologists can improve the odds of detecting depression, anxiety, and other psychiatric disorders if they incorporate key behaviors into their clinical practice. These include:

1. Engage in routine screening for psychosocial distress

Starting in 2015, a new mandate from the American College of Surgeons Commission on Cancer will go into effect requiring cancer centers to implement psychosocial screening to attain accreditation. Assessment should occur at the point of diagnosis, when patients are highly susceptible to distress. But given that some chemotherapies and agents — including immunosuppressive treatments and steroids — can induce depression, routine screening throughout treatment and into survival is also essential.

2. Be willing to have hard conversations

Screening measures, while a worthy start, are not a panacea. Clinicians need to take the initiative to talk to their patients about possible mental health symptoms rather than assuming they will raise the issue as needed.

“Studies have shown that patients are reluctant to bring up psychosocial distress for a variety of reasons,” says Isabel Schuermeyer, MD, Director of Psycho-oncology at the Taussig Cancer Center. “Stigma of mental illness can keep oncologists from asking about it but also can keep patients from talking about it.”

Advertisement

The potential consequences of giving mental health the silent treatment are grave, Dr. Schuermeyer says. A recent study suggests that cancer patients with depression may be less likely to select definitive treatment than patients without depression. Further, there also may be the perception among well-meaning oncologists that depressed patients are simply unable to tolerate the treatment, physically and emotionally, although this is unsupported by data. Similarly, patients may perceive that admitting to feeling depressed or anxious will cause their physician to view them as weak.

3. To refer or not to refer…

Use of screening and engaging in honest dialogue both help open the door to appropriate mental health referral, but oncologists still need to remain vigilant for early clinical warning signs that may warrant specialized care.

“Cancer patients [with mental health needs] who don’t receive psychiatric or psychological treatment early don’t do as well with their cancer treatments,” Dr. Schuermeyer says. “They’re in the hospital longer, their pain is harder to control and they have a harder time adhering to chemotherapies.”

And because they may be more likely to miss chemotherapies or fail to follow their medication regimen, their mortality increases as well.

Although widespread referral of all patients to a psychiatrist or psychologist would be unnecessary, Dr. Schuermeyer does believe that every new cancer patient needing treatment should see a social worker.

“Everyone who is diagnosed with cancer, no matter how resilient they are, is going to have some distress,” she explains, “For most people, that’s very short-lived, but talking to someone about how to take care of yourself and what resources are available is invaluable.”

Advertisement

4. Treat the person, not just the disease.

Embedding a psycho-oncology program directly into the cancer setting — as Cleveland Clinic’s program is positioned — helps convey the message that providers are concerned about the entirety of their patients’ health. Doing so helps patients be seen by a mental health expert at the point of care. It also aids in fostering collaborative relationships between the medical disciplines.

“Mental health care in the cancer patient is vitally important,” says Dr. Schuermeyer. “By working together and maintaining lines of communication, we can help ensure mental health is a routine part of cancer treatment.”

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad